View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Respiratory Infections News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 22, 2024
2 min watch
Save

VIDEO: Hooked on ID with Connie Steed, MSN, RN, CIC, FAPIC

VIDEO: Hooked on ID with Connie Steed, MSN, RN, CIC, FAPIC

SAN ANTONIO — We caught up with Connie Steed, MSN, RN, CIC, FAPIC, at the annual meeting of the Association for Professionals in Infection Control and Epidemiology to find out how she got “Hooked on ID.”

SPONSORED CONTENT
June 21, 2024
4 min read
Save

Q&A: A checkup with CDC Director Mandy K. Cohen, MD, MPH

Q&A: A checkup with CDC Director Mandy K. Cohen, MD, MPH

We checked in with CDC Director Mandy K. Cohen, MD, MPH, for an update on the agency’s efforts to modernize the nation’s disease surveillance and data systems and improve how the CDC communicates with the public and physicians.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
June 18, 2024
3 min read
Save

FDA approves Merck’s pneumococcal vaccine for adults

FDA approves Merck’s pneumococcal vaccine for adults

The FDA has approved Merck’s 21-valent pneumococcal vaccine, which is specifically made for adults, the company announced.

SPONSORED CONTENT
June 14, 2024
3 min read
Save

Q&A: Are combination vaccines the future for respiratory infections?

Q&A: Are combination vaccines the future for respiratory infections?

Moderna announced positive phase 3 trial data for its combination COVID-19 and influenza vaccine this week, suggesting a combination shot for respiratory infections is on the way.

SPONSORED CONTENT
June 13, 2024
3 min read
Save

COVID-19 disrupted RSV seasons, leading to more hospitalizations

COVID-19 disrupted RSV seasons, leading to more hospitalizations

COVID-19 mitigation measures disrupted the circulation of respiratory syncytial virus, leading to atypical season in 2021 and 2022 that saw higher rates of hospitalization among young children, according to research published in Pediatrics.

SPONSORED CONTENT
June 12, 2024
7 min read
Save

Q&A: Will Moderna's mRNA RSV vaccine increase uptake next respiratory virus season?

Q&A: Will Moderna's mRNA RSV vaccine increase uptake next respiratory virus season?

In late May, the FDA announced approval of Moderna's mResvia, marking the third vaccine approved for respiratory syncytial virus and first time messenger RNA technology has been used for preventing a disease other than COVID-19.

SPONSORED CONTENT
June 10, 2024
2 min read
Save

Publicly insured children less likely to receive nirsevimab for RSV

Publicly insured children less likely to receive nirsevimab for RSV

Children in Massachusetts who were publicly insured or living in less affluent ZIP codes were less likely to receive nirsevimab, a monoclonal antibody for respiratory syncytial virus, according to research published in Pediatrics.

SPONSORED CONTENT
June 04, 2024
4 min read
Save

Amikacin safe, improves respiratory symptoms in M. avium complex lung disease

Amikacin safe, improves respiratory symptoms in <i>M.</i><i> </i><i>avium</i> complex lung disease

SAN DIEGO — Amikacin for 6 months improved respiratory symptoms in adults with newly diagnosed or recurrent Mycobacterium avium complex lung disease, according to a presentation at the American Thoracic Society International Conference.

SPONSORED CONTENT
June 03, 2024
2 min read
Save

Entry screening for measles at hospitals may reduce risk for exposure

Entry screening for measles at hospitals may reduce risk for exposure

SAN ANTONIO — A hospital in Seattle started a measles entry screening program for all visitors after an outbreak in the city, finding the measures were easy to put in place and deemed acceptable by patients, according to a study.

SPONSORED CONTENT
May 31, 2024
1 min read
Save

FDA approves Moderna’s mRNA vaccine for RSV

FDA approves Moderna’s mRNA vaccine for RSV

The FDA has approved Moderna's mResvia, a messenger RNA vaccine to protect adults 60 years or older from lower respiratory tract disease caused by respiratory syncytial virus.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails